EMA recommends revoking marketing authorisation for Amgen's rare-disease drug

EMA recommends revoking marketing authorisation for Amgen's rare-disease drug | Reuters — Reuters

EMA recommends revoking marketing authorisation for Amgen's rare-disease drug | Reuters